State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China.
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Haihe Laboratory of Modern Chinese Medicine, Tianjin 301617, China.
Pharmacol Res. 2024 Jan;199:107022. doi: 10.1016/j.phrs.2023.107022. Epub 2023 Dec 1.
Macrophages, as highly phenotypic plastic immune cells, play diverse roles in different pathological conditions. Changing and controlling the phenotypes of macrophages is considered a novel potential therapeutic intervention. Meanwhile, specific transmembrane proteins anchoring on the surface of the macrophage membrane are relatively conserved, supporting its functional properties, such as inflammatory chemotaxis and tumor targeting. Thus, a series of drug delivery systems related to specific macrophage membrane proteins are commonly used to treat chronic inflammatory diseases. This review summarizes macrophages-based strategies for chronic diseases, discusses the regulation of macrophage phenotypes and their polarization processes, and presents how to design and apply the site-specific targeted drug delivery systems in vivo based on the macrophages and their derived membrane receptors. It aims to provide a better understanding of macrophages in immunoregulation and proposes macrophages-based targeted therapeutic approaches for chronic diseases.
巨噬细胞作为高度表型可塑性的免疫细胞,在不同的病理条件下发挥多样化的作用。改变和控制巨噬细胞的表型被认为是一种新的潜在治疗干预手段。同时,锚定在巨噬细胞膜表面的特定跨膜蛋白相对保守,支持其功能特性,如炎症趋化性和肿瘤靶向性。因此,一系列与特定巨噬细胞膜蛋白相关的药物递送系统常用于治疗慢性炎症性疾病。本综述总结了基于巨噬细胞的慢性疾病治疗策略,讨论了巨噬细胞表型的调控及其极化过程,并介绍了如何基于巨噬细胞及其衍生的膜受体设计和应用体内的特异性靶向药物递送系统。旨在更好地理解巨噬细胞在免疫调节中的作用,并为慢性疾病提出基于巨噬细胞的靶向治疗方法。